SUMITOMO CHEM INDIA LTD (SUMICHEM) financials
SUMITOMO CHEM INDIA LTD (SUMICHEM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health bus…
- Market Cap: ₹19,584Cr.
- Current Price: ₹392
- Stock P/E: 34.3
- ROE: 17.6%
- ROCE: 23.5%
- Book Value: ₹67.8
- Dividend Yield: 0.33%
- 52W High / Low: ₹573/363
In Jun 2026, SUMITOMO CHEM INDIA LTD (SUMICHEM) reported sales ₹1,054 Cr and net profit ₹217 Cr.
Annual TTM: sales ₹3,192 Cr, net profit ₹580 Cr.
Shareholding: Promoters 75.00% (Sep 2026), FIIs 2.89% (Sep 2026), DIIs 9.68% (Sep 2026), Public 12.42% (Sep 2026), No. of Shareholders 1,09,118% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 971 | 622 | 665 | 1,048 | 914 | 552 | 671 | 1,054 |
| Expenses | 729 | 521 | 548 | 828 | 697 | 456 | 539 | 819 |
| Operating Profit | 242 | 101 | 117 | 220 | 217 | 96 | 133 | 235 |
| OPM % | 25% | 16% | 18% | 21% | 24% | 17% | 20% | 22% |
| Other Income | 31 | 31 | 31 | 39 | 39 | 22 | 32 | 74 |
| Interest | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 15 | 18 | 16 | 15 | 16 | 16 | 16 | 16 |
| Profit before tax | 257 | 113 | 132 | 242 | 238 | 100 | 147 | 291 |
| Tax % | 26% | 25% | 25% | 26% | 25% | 25% | 25% | 26% |
| Net Profit | 191 | 84 | 98 | 180 | 178 | 75 | 111 | 217 |
| EPS in Rs | 3.82 | 1.69 | 1.97 | 3.60 | 3.56 | 1.50 | 2.22 | 4.34 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 | 3,186 | 3,192 |
| Expenses | 2,088 | 2,155 | 2,458 | 2,843 | 2,358 | 2,467 | 2,520 | 2,511 |
| Operating Profit | 335 | 488 | 603 | 668 | 474 | 623 | 666 | 680 |
| OPM % | 14% | 18% | 20% | 19% | 17% | 20% | 21% | 21% |
| Other Income | -20 | 19 | 36 | 45 | 96 | 119 | 131 | 166 |
| Interest | 7 | 7 | 8 | 6 | 5 | 6 | 7 | 7 |
| Depreciation | 41 | 47 | 45 | 52 | 61 | 63 | 63 | 64 |
| Profit before tax | 267 | 453 | 586 | 655 | 503 | 674 | 727 | 776 |
| Tax % | 23% | 24% | 26% | 23% | 27% | 26% | 25% | — |
| Net Profit | 206 | 345 | 434 | 503 | 370 | 502 | 543 | 580 |
| EPS in Rs | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 | 10.06 | 10.88 | 11.62 |
| Dividend Payout % | 18% | 12% | 12% | 12% | 80% | 12% | 12% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 275 | 499 | 499 | 499 | 499 | 499 | 499 | 499 |
| Reserves | 761 | 710 | 1,029 | 1,425 | 1,881 | 1,941 | 2,397 | 2,885 |
| Borrowings | 20 | 36 | 33 | 38 | 34 | 25 | 45 | 53 |
| Other Liabilities | 791 | 848 | 1,097 | 1,047 | 955 | 822 | 988 | 997 |
| Total Liabilities | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 |
| Fixed Assets | 279 | 319 | 309 | 390 | 430 | 489 | 482 | 499 |
| CWIP | 8 | 10 | 14 | 35 | 71 | 23 | 28 | 20 |
| Investments | 1 | 87 | 291 | 357 | 239 | 425 | 601 | 1,226 |
| Other Assets | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,351 | 2,819 | 2,690 |
| Total Assets | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 | 4,434 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 75 | 222 | 424 | 223 | 389 | 756 | 458 | 443 |
| Cash from Investing Activity | -35 | -118 | -282 | -281 | -327 | -426 | -405 | -329 |
| Cash from Financing Activity | -65 | -61 | -47 | -63 | -73 | -331 | -65 | -81 |
| Net Cash Flow | -26 | 43 | 95 | -120 | -10 | -1 | -11 | 33 |
| Free Cash Flow | 36 | 184 | 382 | 111 | 270 | 695 | 431 | 404 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 56% | 90% | 109% | 61% | 83% | 187% | 100% | 91% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| FIIs | 3.59% | 3.63% | 3.65% | 3.65% | 3.37% | 3.41% | 3.02% | 2.89% |
| DIIs | 6.96% | 8.13% | 8.15% | 8.47% | 8.65% | 8.98% | 9.33% | 9.68% |
| Public | 14.44% | 13.23% | 13.19% | 12.88% | 12.97% | 12.60% | 12.65% | 12.42% |
| No. of Shareholders | 1,25,812 | 1,24,650 | 1,24,950 | 1,15,793 | 1,14,878 | 1,11,892 | 1,10,464 | 1,09,118 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 128 | 117 | 101 | 98 | 91 | 90 | 81 |
| Inventory Days | 193 | 133 | 185 | 198 | 157 | 135 | 154 | 166 |
| Days Payable | 136 | 112 | 145 | 110 | 87 | 96 | 107 | 86 |
| Cash Conversion Cycle | 167 | 150 | 157 | 189 | 168 | 131 | 136 | 161 |
| Working Capital Days | 116 | 109 | 95 | 127 | 136 | 173 | 183 | 155 |
| ROCE % | 27% | 26% | 33% | 34% | 30% | 21% | 25% | 23% |
Sumitomo Chem India Ltd
₹19,584Cr.
₹392
₹573/363
34.3
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1][2]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of SUMITOMO CHEM INDIA LTD (SUMICHEM)?
The reported market capitalisation for SUMITOMO CHEM INDIA LTD (SUMICHEM) is ₹19,584Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of SUMICHEM?
The current price shown for SUMITOMO CHEM INDIA LTD (SUMICHEM) on Fincrux is ₹392 with a 52-week high/low of ₹573/363.
What is the P/E ratio of SUMITOMO CHEM INDIA LTD (SUMICHEM)?
The stock P/E for SUMITOMO CHEM INDIA LTD (SUMICHEM) is 34.3 on Fincrux, with ROE at 17.6% and ROCE at 23.5%.
What were SUMICHEM latest quarterly results?
For Jun 2026, SUMITOMO CHEM INDIA LTD (SUMICHEM) reported sales ₹1,054 Cr and net profit ₹217 Cr (figures in ₹ crore unless noted).
What are SUMICHEM annual sales and net profit?
For TTM, SUMITOMO CHEM INDIA LTD (SUMICHEM) shows sales of ₹3,192 Cr and net profit of ₹580 Cr on the Fincrux profit & loss statement.
Who owns SUMITOMO CHEM INDIA LTD (SUMICHEM)?
Latest shareholding for SUMITOMO CHEM INDIA LTD (SUMICHEM) on Fincrux: Promoters 75.00% (Sep 2026), FIIs 2.89% (Sep 2026), DIIs 9.68% (Sep 2026), Public 12.42% (Sep 2026), No. of Shareholders 1,09,118% (Sep 2026).
Where can I find SUMITOMO CHEM INDIA LTD (SUMICHEM) financials?
SUMITOMO CHEM INDIA LTD (SUMICHEM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show SUMICHEM balance sheet and cash flow?
Yes. The SUMITOMO CHEM INDIA LTD (SUMICHEM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.